Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Larimar Therapeutics (LRMR) Shares Issued (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Shares Issued for 6 consecutive years, with $19.3 million as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Shares Issued fell 70.03% year-over-year to $19.3 million, compared with a TTM value of $35.2 million through Dec 2019, down 45.73%, and an annual FY2024 reading of $161.8 million, up 539253.33% over the prior year.
  • Shares Issued was $19.3 million for Q4 2019 at Larimar Therapeutics, up from $9.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $129.1 million in Q4 2015 and bottomed at $40000.0 in Q1 2017.
  • Average Shares Issued over 5 years is $13.6 million, with a median of $261000.0 recorded in 2018.
  • Peak annual rise in Shares Issued hit 3977.46% in 2019, while the deepest fall reached 70.03% in 2019.
  • Year by year, Shares Issued stood at $129.1 million in 2015, then plummeted by 99.87% to $165000.0 in 2016, then tumbled by 51.52% to $80000.0 in 2017, then surged by 80236.25% to $64.3 million in 2018, then crashed by 70.03% to $19.3 million in 2019.
  • Business Quant data shows Shares Issued for LRMR at $19.3 million in Q4 2019, $9.9 million in Q3 2019, and $3.0 million in Q2 2019.